Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

BATS BZX Real-Time Price
As of 1:25pm ET
 -0.37 / -2.69%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 14.00. The median estimate represents a +49.48% increase from the last price of 13.38.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.13%
Growthannually -75.64%


Growthquarterly -1.43%
Growthannually -26.79%
Key to the earnings and sales forecast charts.